• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNovartis

Novartis

Page 3 of 4
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
HealthThe FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By Sy MukherjeeOctober 19, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthNovartis CEO Joseph Jimenez Is Stepping Down
By David MeyerSeptember 4, 2017
HealthIs $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
CommentaryInnovative Drugs Deserve Innovative Pricing
By David Agus, Dana Goldman and Bethany CiancioloAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthThe Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
Close-up of young man placing blue and white tablet into mouth
HealthThis Drug Is A Dual Threat Against Heart Disease and Cancer
By Clifton LeafAugust 28, 2017
HealthInvesting in Healthcare: Two Starkly Different Views
By Clifton LeafJuly 13, 2017
HealthFDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By Sy MukherjeeJuly 12, 2017
The logo of the World Economic Forum is seen in the congress center of the annual meeting of the World Economic Forum (WEF) in Davos
HealthThese World Leaders Have a Radical Idea for Health Care
By Sy MukherjeeApril 27, 2017
TechGoogle and Novartis Won’t Be Testing Smart Contact Lenses This Year After All
By ReutersNovember 18, 2016
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
HealthNovartis Says MS Drug Cut Risk of Disability Advance in Study
By ReutersSeptember 17, 2016
The Davos World Economic Forum 2015
HealthNovartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By Sy MukherjeeAugust 31, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
HealthNovartis Asthma Pill Shows Promise in Small Trial
By ReutersAugust 6, 2016
The Davos World Economic Forum 2015
HealthAmgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis
By Sy MukherjeeJuly 19, 2016
Close up of surgical tools and money
HealthTwo of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
By Sy MukherjeeJuly 15, 2016
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.